The NIH Parent R35 Investigator-Focused Award provides stable, flexible funding to support researchers’ overall programs, enabling scientific freedom and innovation across all career stages.
NIAMS offers eligible career development award recipients up to $50,000 per year for two years for small research projects supporting a transition to independence; clinical trials are excluded.
NIH supports eligible NIGMS-funded and new investigators through a single, flexible research grant aligned with NIGMS' mission, with renewals open to current MIRA grantees.
NIH's R21 grant supports early-stage, high-risk clinical trial research with potential for breakthroughs in biomedical, behavioral, or clinical fields.
The NHLBI Emerging Investigator Award (EIA) provides long-term support for experienced PDs/PIs with a strong research record to make significant contributions to heart, lung, blood, and sleep research.
This grant provides salary and travel support for experienced, non-tenure track scientists in core labs or research facilities who make essential contributions to NCI-funded cancer research but are not independent investigators.